{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T15:07:32Z","timestamp":1778425652289,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Breast cancer is the most common cancer in women worldwide. Hormone receptor breast cancers are the most common ones and, about 2 out of every 3 cases of breast cancer are estrogen receptor (ER) positive. Selective ER modulators, such as tamoxifen, are the first line of endocrine treatment of breast cancer. Despite the expression of hormone receptors some patients develop tamoxifen resistance and 50% present de novo tamoxifen resistance. Recently, we have demonstrated that activated mammalian target of rapamycin (mTOR) is positively associated with overall survival and recurrence free survival in ER positive breast cancer patients who were later treated with tamoxifen. Since altered expression of protein kinase B (PKB)\/Akt in breast cancer cells affect N-myristoyltransferase 1 (NMT1) expression and activity, we investigated whether mTOR, a downstream target of PKB\/Akt, regulates NMT1 in ER positive breast cancer cells (MCF7 cells). We inhibited mTOR by treating MCF7 cells with rapamycin and observed that the expression of NMT1 increased with rapamycin treatment over the period of time with a concomitant decrease in mTOR phosphorylation. We further employed mathematical modelling to investigate hitherto not known relationship of mTOR with NMT1. We report here for the first time a collection of models and data validating regulation of NMT1 by mTOR.<\/jats:p>","DOI":"10.1038\/s41598-018-30447-0","type":"journal-article","created":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T10:39:42Z","timestamp":1534934382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Investigation of Novel Regulation of N-myristoyltransferase by Mammalian Target of Rapamycin in Breast Cancer Cells"],"prefix":"10.1038","volume":"8","author":[{"given":"Marine","family":"Jacquier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiby","family":"Kuriakose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apurva","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuraag","family":"Shrivastav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Portet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailly","family":"Varma Shrivastav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,28]]},"reference":[{"key":"30447_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrc721","volume":"2","author":"S Ali","year":"2002","unstructured":"Ali, S. & Coombes, R. C. Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2, 101\u2013112, https:\/\/doi.org\/10.1038\/nrc721 (2002).","journal-title":"Nat Rev Cancer"},{"key":"30447_CR2","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nrc2713","volume":"9","author":"EA Musgrove","year":"2009","unstructured":"Musgrove, E. A. & Sutherland, R. L. Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 9, 631\u2013643, https:\/\/doi.org\/10.1038\/nrc2713 (2009).","journal-title":"Nat Rev Cancer"},{"key":"30447_CR3","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/annonc\/mdm170","volume":"18","author":"M Beeram","year":"2007","unstructured":"Beeram, M. et al. Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling. Ann Oncol 18, 1323\u20131328, https:\/\/doi.org\/10.1093\/annonc\/mdm170 (2007).","journal-title":"Ann Oncol"},{"key":"30447_CR4","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1158\/1078-0432.CCR-04-2402","volume":"11","author":"A Boulay","year":"2005","unstructured":"Boulay, A. et al. Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer. Clin. cancer research: an official journal Am. Assoc. for Cancer Res. 11, 5319\u20135328, https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-2402 (2005).","journal-title":"Clin. cancer research: an official journal Am. Assoc. for Cancer Res."},{"key":"30447_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3660","volume":"16","author":"A Shrivastav","year":"2014","unstructured":"Shrivastav, A. et al. The mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-\u03b1 in human breast tumors in vivo. Breast Cancer Res 16, R49, https:\/\/doi.org\/10.1186\/bcr3660 (2014).","journal-title":"Breast Cancer Res"},{"key":"30447_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrd2926","volume":"8","author":"P Liu","year":"2009","unstructured":"Liu, P., Cheng, H., Roberts, T. M. & Zhao, J. J. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov. 8, 627\u201344, https:\/\/doi.org\/10.1038\/nrd2926 (2009).","journal-title":"Nat Rev Drug Discov."},{"key":"30447_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","volume":"124","author":"S Wullschleger","year":"2006","unstructured":"Wullschleger, S., Loewith, R. & Hall, M. N. TOR signaling in growth and metabolism. Cell 124, 471\u201384, https:\/\/doi.org\/10.1016\/j.cell.2006.01.016 (2006).","journal-title":"Cell"},{"key":"30447_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1083\/jcb.201306041","volume":"203","author":"C Betz","year":"2013","unstructured":"Betz, C. & Hall, M. N. Where is mTOR and what is it doing there? The Journal of Cell Biology 203, 563\u201374, https:\/\/doi.org\/10.1083\/jcb.201306041 (2013).","journal-title":"The Journal of Cell Biology"},{"key":"30447_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.devcel.2007.03.020","volume":"12","author":"PT Bhaskar","year":"2007","unstructured":"Bhaskar, P. T. & Hay, N. The two TORCs and akt. Dev Cell 12, 487\u2013502, https:\/\/doi.org\/10.1016\/j.devcel.2007.03.020 (2007).","journal-title":"Dev Cell"},{"key":"30447_CR10","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.4161\/cc.6.24.5085","volume":"6","author":"D-F Lee","year":"2007","unstructured":"Lee, D.-F. & Hung, M.-C. All roads lead to mTOR: Integrating inflammation and tumor angiogenesis. Cell Cycle 6, 3011\u20134, https:\/\/doi.org\/10.4161\/cc.6.24.5085 (2007).","journal-title":"Cell Cycle"},{"key":"30447_CR11","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.2146\/ajhp100020","volume":"67","author":"EB Borders","year":"2010","unstructured":"Borders, E. B., Bivona, C. & Medina, P. J. Mammalian target of rapamycin: Biological function and target for novel anticancer agents. Am J Health Syst Pharm 67, 2095\u2013106, https:\/\/doi.org\/10.2146\/ajhp100020 (2010).","journal-title":"Am J Health Syst Pharm"},{"key":"30447_CR12","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1101\/gad.1212704","volume":"18","author":"N Hay","year":"2004","unstructured":"Hay, N. & Sonenberg, N. Upstream and downstream of mtor. Genes Dev 18, 1926\u201345, https:\/\/doi.org\/10.1101\/gad.1212704 (2004).","journal-title":"Genes Dev"},{"key":"30447_CR13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.7164\/antibiotics.28.721","volume":"28","author":"C V\u00e9zina","year":"1975","unstructured":"V\u00e9zina, C., Kudelski, A. & Sehgal, S. N. Rapamycin (AY-22,989), a new antifungal antibiotic. i. taxonomy of the producing streptomycete and isolation of the active principle. The Journal of Antibiotics 28, 721\u20136, https:\/\/doi.org\/10.7164\/antibiotics.28.721 (1975).","journal-title":"The Journal of Antibiotics"},{"key":"30447_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1755-148X.2010.00796.x","volume":"24","author":"H Populo","year":"2011","unstructured":"Populo, H. et al. mTOR pathway activation in cutaneous melanoma is associated with poorer prognosis characteristics. Pigment Cell Melanoma Res 24, 254\u20137 (2011).","journal-title":"Pigment Cell Melanoma Res"},{"key":"30447_CR15","doi-asserted-by":"crossref","first-page":"8647","DOI":"10.1016\/S0021-9258(18)31490-X","volume":"266","author":"JI Gordon","year":"1991","unstructured":"Gordon, J. I., Duronio, R. J., Rudnick, D. A., Adams, S. P. & Gokel, G. W. Protein n-myristoylation. J Biol Chem 266, 8647\u201350 (1991).","journal-title":"J Biol Chem"},{"key":"30447_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0898-6568(96)00100-3","volume":"9","author":"JA Boutin","year":"1997","unstructured":"Boutin, J. A. Myristoylation. Cell Signalling 9, 15\u201335, https:\/\/doi.org\/10.1016\/s0898-6568(96)00100-3 (1997).","journal-title":"Cell Signalling"},{"key":"30447_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.abb.2004.09.003","volume":"433","author":"MW Vetting","year":"2005","unstructured":"Vetting, M. W. et al. Structure and functions of the GNAT superfamily of acetyltransferases. Arch Biochem Biophys 433, 212\u201326, https:\/\/doi.org\/10.1016\/j.abb.2004.09.003 (2005).","journal-title":"Arch Biochem Biophys"},{"key":"30447_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1385\/CBB:43:1:189","volume":"43","author":"A Shrivastav","year":"2005","unstructured":"Shrivastav, A. et al. Regulation of N-myristoyltransferase by novel inhibitor proteins. Cell Biochem Biophys 43, 189\u2013202, https:\/\/doi.org\/10.1385\/cbb:43:1:189 (2005).","journal-title":"Cell Biochem Biophys"},{"key":"30447_CR19","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1073\/pnas.84.9.2708","volume":"84","author":"DA Towler","year":"1987","unstructured":"Towler, D. A. et al. Purification and characterization of yeast myristoyl coa:protein n-myristoyltransferase. Proceedings of the National Academy of Sciences 84, 2708\u201312, https:\/\/doi.org\/10.1073\/pnas.84.9.2708 (1987).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"30447_CR20","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/S0021-9258(17)42038-2","volume":"269","author":"JK Lodge","year":"1994","unstructured":"Lodge, J. K., Jackson-Machelski, E., Toffaletti, D. L., Perfect, J. R. & Gordon, J. I. Comparison of myristoyl-coa:protein n-myristoyltransferases from three pathogenic fungi: Cryptococcus neoformans, histoplasma capsulatum, and candida albicans. J Biol Chem 269, 2996\u20133009 (1994).","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"30447_CR21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1042\/bj3480459","volume":"348","author":"RS Gunaratne","year":"2000","unstructured":"Gunaratne, R. S. et al. Characterization of n-myristoyltransferase from plasmodium falciparum. Biochem J 348(Pt 2), 459\u201363, https:\/\/doi.org\/10.1042\/0264-6021:3480459 (2000).","journal-title":"Biochem J"},{"key":"30447_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1042\/BJ20051886","volume":"396","author":"C Panethymitaki","year":"2006","unstructured":"Panethymitaki, C. et al. Characterization and selective inhibition of myristoyl-coa:protein n-myristoyltransferase fromtrypanosoma brucei andleishmania major. Biochem J 396, 277\u201385, https:\/\/doi.org\/10.1042\/bj20051886 (2006).","journal-title":"Biochem J"},{"key":"30447_CR23","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1074\/jbc.273.12.6595","volume":"273","author":"DK Giang","year":"1998","unstructured":"Giang, D. K. & Cravatt, B. F. A second MammalianN-myristoyltransferase. J Biol Chem 273, 6595\u20138, https:\/\/doi.org\/10.1074\/jbc.273.12.6595 (1998).","journal-title":"J Biol Chem"},{"key":"30447_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11010-005-9108-0","volume":"286","author":"V Rioux","year":"2006","unstructured":"Rioux, V. et al. Identification and characterization of recombinant and native rat myristoyl-CoA: protein n-myristoyltransferases. Mol Cell Biochem 286, 161\u201370, https:\/\/doi.org\/10.1007\/s11010-005-9108-0 (2006).","journal-title":"Mol Cell Biochem"},{"key":"30447_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11064-004-9680-9","volume":"30","author":"Y Lu","year":"2005","unstructured":"Lu, Y. et al. Expression of n-myristoyltransferase in human brain tumors. Neurochem Res 30, 9\u201313, https:\/\/doi.org\/10.1007\/s11064-004-9680-9 (2005).","journal-title":"Neurochem Res"},{"key":"30447_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plipres.2006.05.002","volume":"46","author":"P Selvakumar","year":"2007","unstructured":"Selvakumar, P. et al. Potential role of n-myristoyltransferase in cancer. Prog Lipid Res 46, 1\u201336, https:\/\/doi.org\/10.1016\/j.plipres.2006.05.002 (2007).","journal-title":"Prog Lipid Res"},{"key":"30447_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3892\/or.18.1.93","volume":"18","author":"A Shrivastav","year":"2007","unstructured":"Shrivastav, A. et al. Elevated n-myristoyltransferase activity and expression in oral squamous cell carcinoma. Oncol Rep 18, 93\u20137, https:\/\/doi.org\/10.3892\/or.18.1.93 (2007).","journal-title":"Oncol Rep"},{"key":"30447_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-5-58","volume":"5","author":"A Shrivastav","year":"2007","unstructured":"Shrivastav, A., Varma, S., Saxena, A., DeCoteau, J. & Sharma, R. K. N-myristoyltransferase: A potential novel diagnostic marker for colon cancer. Journal of Translational Medicine 5, 58, https:\/\/doi.org\/10.1186\/1479-5876-5-58 (2007).","journal-title":"Journal of Translational Medicine"},{"key":"30447_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/path.2550","volume":"218","author":"A Shrivastav","year":"2009","unstructured":"Shrivastav, A. et al. Overexpression of Akt\/PKB modulates N-myristoyltransferase activity in cancer cells. The Journal of Pathology 218, 391\u20138, https:\/\/doi.org\/10.1002\/path.2550 (2009).","journal-title":"The Journal of Pathology"},{"key":"30447_CR30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/0014-5793(82)80759-X","volume":"150","author":"A Aitken","year":"1982","unstructured":"Aitken, A. et al. Identification of the NH2-terminal blocking group of calcineurin b as myristic acid. FEBS Letters 150, 314\u20138, https:\/\/doi.org\/10.1016\/0014-5793(82)80759-x (1982).","journal-title":"FEBS Letters"},{"key":"30447_CR31","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1093\/jnci\/87.21.1630","volume":"87","author":"BA Magnuson","year":"1995","unstructured":"Magnuson, B. A., Raju, R. V. S., Moyana, T. N. & Sharma, R. K. Increased n-myristoyltransferase activity observed in rat and human colonic tumors. JNCI Journal of the National Cancer Institute 87, 1630\u20135, https:\/\/doi.org\/10.1093\/jnci\/87.21.1630 (1995).","journal-title":"JNCI Journal of the National Cancer Institute"},{"key":"30447_CR32","doi-asserted-by":"publisher","unstructured":"Pezze, P. D. et al. A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation. Sci Signal 5, ra25\u2013ra25, https:\/\/doi.org\/10.1126\/scisignal.2002469 (2012).","DOI":"10.1126\/scisignal.2002469"},{"key":"30447_CR33","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1111\/j.1742-4658.2012.08582.x","volume":"279","author":"AG Sonntag","year":"2012","unstructured":"Sonntag, A. G., Pezze, P. D., Shanley, D. P. & Thedieck, K. A modelling-experimental approach reveals insulin receptor substrate (IRS)-dependent regulation of adenosine monosphosphate-dependent kinase (AMPK) by insulin. FEBS Journal 279, 3314\u20133328, https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08582.x (2012).","journal-title":"FEBS Journal"},{"key":"30447_CR34","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.molcel.2012.04.018","volume":"46","author":"H Kubota","year":"2012","unstructured":"Kubota, H. et al. Temporal coding of insulin action through multiplexing of the AKT pathway. Molecular Cell 46, 820\u2013832, https:\/\/doi.org\/10.1016\/j.molcel.2012.04.018 (2012).","journal-title":"Molecular Cell"},{"key":"30447_CR35","doi-asserted-by":"publisher","first-page":"e1379","DOI":"10.1002\/wsbm.1379","volume":"9","author":"N Sulaimanov","year":"2017","unstructured":"Sulaimanov, N., Klose, M., Busch, H. & Boerries, M. Understanding the mTOR signaling pathway via mathematical modeling. Wiley Interdiscip Rev Syst Biol Med 9, e1379, https:\/\/doi.org\/10.1002\/wsbm.1379 (2017).","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"30447_CR36","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nrd2381","volume":"6","author":"RP Araujo","year":"2007","unstructured":"Araujo, R. P., Liotta, L. A. & Petricoin, E. F. Proteins, drug targets and the mechanisms they control: the simple truth about complex networks. Nat Rev Drug Discovery 6, 871\u2013880, https:\/\/doi.org\/10.1038\/nrd2381 (2007).","journal-title":"Nat Rev Drug Discovery"},{"key":"30447_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.semcdb.2015.09.024","volume":"50","author":"LK Nguyen","year":"2016","unstructured":"Nguyen, L. K. & Kholodenko, B. N. Feedback regulation in cell signalling: Lessons for cancer therapeutics. Seminars in Cell & Developmental Biology 50, 85\u201394, https:\/\/doi.org\/10.1016\/j.semcdb.2015.09.024 (2016).","journal-title":"Seminars in Cell & Developmental Biology"},{"key":"30447_CR38","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1039\/b816965a","volume":"5","author":"PKU Vinod","year":"2009","unstructured":"Vinod, P. K. U. & Venkatesh, K. V. Quantification of the effect of amino acids on an integrated mTOR and insulin signaling pathway. Molecular BioSystems 5, 1163, https:\/\/doi.org\/10.1039\/b816965a (2009).","journal-title":"Molecular BioSystems"},{"key":"30447_CR39","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ncb1183","volume":"6","author":"E Jacinto","year":"2004","unstructured":"Jacinto, E. et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6, 1122\u20138, https:\/\/doi.org\/10.1038\/ncb1183 (2004).","journal-title":"Nat Cell Biol"},{"key":"30447_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","volume":"110","author":"D-H Kim","year":"2002","unstructured":"Kim, D.-H. et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163\u201375, https:\/\/doi.org\/10.1016\/s0092-8674(02)00808-5 (2002).","journal-title":"Cell"},{"key":"30447_CR41","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1016\/S0021-9258(19)34041-4","volume":"265","author":"J Driscoll","year":"1990","unstructured":"Driscoll, J. & Goldberg, A. L. The proteasome (multicatalytic protease) is a component of the 1500-kda proteolytic complex which degrades ubiquitin-conjugated proteins. The Journal of biological chemistry 265, 4789\u20134792 (1990).","journal-title":"The Journal of biological chemistry"},{"key":"30447_CR42","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1126\/science.273.5282.1725","volume":"273","author":"MM Hiller","year":"1996","unstructured":"Hiller, M. M., Finger, A., Schweiger, M. & Wolf, D. H. ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway. Science 273, 1725\u20138, https:\/\/doi.org\/10.1126\/science.273.5282.1725 (1996).","journal-title":"Science"},{"key":"30447_CR43","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/ncb0805-731","volume":"7","author":"J Pines","year":"2005","unstructured":"Pines, J. & Lindon, C. Proteolysis: anytime, any place, anywhere? Nat Cell Biol 7, 731\u20135, https:\/\/doi.org\/10.1038\/ncb0805-731 (2005).","journal-title":"Nat Cell Biol"},{"key":"30447_CR44","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1158\/0008-5472.CAN-08-1751","volume":"69","author":"H Wang","year":"2009","unstructured":"Wang, H. et al. Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer. Cancer Res 69, 1063\u201370, https:\/\/doi.org\/10.1158\/0008-5472.can-08-1751 (2009).","journal-title":"Cancer Res"},{"key":"30447_CR45","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1167\/iovs.09-4087","volume":"51","author":"EJ Dudek","year":"2010","unstructured":"Dudek, E. J. et al. Ubiquitin proteasome pathway-mediated degradation of proteins: Effects due to site-specific substrate deamidation. Investigative ophthalmology & visual science 51, 4164\u201373, https:\/\/doi.org\/10.1167\/iovs.09-4087 (2010).","journal-title":"Investigative ophthalmology & visual science"},{"key":"30447_CR46","doi-asserted-by":"publisher","first-page":"26448","DOI":"10.1074\/jbc.M500373200","volume":"280","author":"L Sun","year":"2005","unstructured":"Sun, L., Trausch-Azar, J. S., Ciechanover, A. & Schwartz, A. L. Ubiquitin-proteasome-mediated degradation, intracellular localization, and protein synthesis of MyoD and id1 during muscle differentiation. J Biol Chem 280, 26448\u201356, https:\/\/doi.org\/10.1074\/jbc.m500373200 (2005).","journal-title":"J Biol Chem"},{"key":"30447_CR47","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/nature16472","volume":"529","author":"J Zhao","year":"2016","unstructured":"Zhao, J., Garcia, G. A. & Goldberg, A. L. Control of proteasomal proteolysis by mTOR. Nature 529, E1\u20132, https:\/\/doi.org\/10.1038\/nature16472 (2016).","journal-title":"Nature"},{"key":"30447_CR48","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nature13492","volume":"513","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. Coordinated regulation of protein synthesis and degradation by mtorc1. Nature 513, 440\u2013443, https:\/\/doi.org\/10.1038\/nature13492 (2014).","journal-title":"Nature"},{"key":"30447_CR49","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1105\/tpc.113.111393","volume":"25","author":"L Renna","year":"2013","unstructured":"Renna, L. et al. Golgi traffic and integrity depend on n-myristoyl transferase-1 in arabidopsis. The Plant Cell 25, 1756\u201373, https:\/\/doi.org\/10.1105\/tpc.113.111393 (2013).","journal-title":"The Plant Cell"},{"key":"30447_CR50","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/jcb.10189","volume":"86","author":"NA Syed","year":"2002","unstructured":"Syed, N. A., Horner, K. N., Misra, V. & Khandelwal, R. L. Different cellular localization, translocation, and insulin-induced phosphorylation of PKBalpha in HepG2 cells and hepatocytes. J Cell Biochem 86, 118\u201327, https:\/\/doi.org\/10.1002\/jcb.10189 (2002).","journal-title":"J Cell Biochem"},{"key":"30447_CR51","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/ncb1497","volume":"8","author":"BB Aldridge","year":"2006","unstructured":"Aldridge, B. B., Burke, J. M., Lauffenburger, D. A. & Sorger, P. K. Physicochemical modelling of cell signalling pathways. Nat Cell Biol 8, 1195\u20131203, https:\/\/doi.org\/10.1038\/ncb1497 (2006).","journal-title":"Nat Cell Biol"},{"key":"30447_CR52","doi-asserted-by":"crossref","unstructured":"Klipp, E., Herwig, R., Kowald, A., Wierling, C. & Lehrach, H. Systems Biology in Practice: Concepts, Implementation and Application (Wiley-Blackwell, 2005).","DOI":"10.1002\/3527603603"},{"key":"30447_CR53","doi-asserted-by":"crossref","unstructured":"Burnham, K. P. & Anderson, D. R. Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach (Springer, 2003).","DOI":"10.1007\/b97636"},{"key":"30447_CR54","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3758\/BF03206482","volume":"11","author":"E-J Wagenmakers","year":"2004","unstructured":"Wagenmakers, E.-J. & Farrell, S. AIC model selection using Akaike weights. Psychonomic Bulletin & Review 11, 192\u2013196, https:\/\/doi.org\/10.3758\/bf03206482 (2004).","journal-title":"Psychonomic Bulletin & Review"},{"key":"30447_CR55","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jtbi.2008.04.011","volume":"254","author":"S Marino","year":"2008","unstructured":"Marino, S., Hogue, I. B., Ray, C. J. & Kirschner, D. E. A methodology for performing global uncertainty and sensitivity analysis in systems biology. J Theor Biol 254, 178\u2013196, https:\/\/doi.org\/10.1016\/j.jtbi.2008.04.011 (2008).","journal-title":"J Theor Biol"},{"key":"30447_CR56","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1049\/iet-syb.2011.0015","volume":"5","author":"Z Zi","year":"2011","unstructured":"Zi, Z. Sensitivity analysis approaches applied to systems biology models. IET Syst Biol 5, 336\u2013346, https:\/\/doi.org\/10.1049\/iet-syb.2011.0015 (2011).","journal-title":"IET Syst Biol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30447-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30447-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30447-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:59:58Z","timestamp":1671613198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30447-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,28]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["30447"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-30447-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,28]]},"assertion":[{"value":"11 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12969"}}